CEOInterviews.AI
Start App
Get an email when Mark Cuban gives a new interview
One email per new interview. Unsubscribe in one click.
Mark Cuban
Co-founder; minority owner, Dallas Mavericks, Cost Plus Drugs

Mark Cuban on Breaking the System: From Big Pharma to Doing What’s Right

📅 Dec 03, 2025 The Other 80 42 MIN 547 VIEWS 71 SEGMENTS · 2 SPEAKERS
Billionaire investor and healthcare disruptor Mark Cuban joins The Other 80 to talk about how his online pharmacy, Cost Plus Drugs, is changing the game when it comes to drug prices. In this powerful conversation with host Claudia Williams, they dive into radical transparency and how being open about pricing can disrupt the pharmaceutical industry's status quo. Mark shares his formula for taking overhead and complexity out of the US healthcare system and outlines how direct negotiations for fair prices could become the new norm. In this episode, Mark Cuban pitches on: Why direct contracting...

Questions asked in this interview

12
  1. 0:24But I want to ask you a slightly different question, which is, what do people get wrong about you?
  2. 1:38Is it radical? What made it possible?
  3. 2:54How do you go about disrupting that other than through your model?
  4. 11:07Five years from now, where do you want to be?
  5. 13:29If you were to pick another sector or subsector within healthcare that has similar disruption opportunities, what would it be, and why, and how would you get going?
  6. 19:02Will you also expand, like manage that process for other employers that might want to work with you?
  7. 21:04If we were to design capitalism for actual health, what would be your working rules for that?
  8. 27:46So there, you know, you could go and just buy it directly, but really you want someone to guide that decision, right?
  9. 29:11And so if you had a room full of Medicaid policymakers who were willing to start to take some of those steps, what would you tell them to do?
  10. 34:14So, what do you think about Kaiser and other models like that?
  11. 35:16What's a time you failed and what did that teach you about how to do it next time?
  12. 39:50One: what is your own personal health routine?
Mark Cuban 0:00 ↗
I don't fail. I failed so many times. But you know, with failure, particularly like Cost Plus Drugs, you iterate. You learn and you iterate. Like I tell every kid I talk to, it doesn't matter how many times you fail, you only got to be right one time. Then everybody can call you an overnight success. What I do well is I'm okay with mistakes.
Claudia Williams 0:24 ↗
Well, hi Mark. So great to have you on the show. And thanks for having me. You know, we usually cover the last six months of news, and there was a lot to cover with you, including from last week. And you know, my first question to guests is always, what should we know about them? Because often there's something important inside the story. But I want to ask you a slightly different question, which is, what do people get wrong about you?
Mark Cuban 0:50 ↗
I think they look at my bank account because whenever somebody sees something written about me, they always say billionaire Mark Cuban. And I'm not sad to be a billionaire, but I think people use that and their perception of what that means to decide what I'm about and what I'm like. And you know, my bank account does not define me. It didn't define me when I was broke sleeping on the floor, and it doesn't define me now.
Claudia Williams 1:16 ↗
And what does?
Mark Cuban 1:17 ↗
I think what I'm trying to accomplish, that you know that I'm trying to give something back, that I'm trying to spend as much time as I can with my family while you know my kids are still accessible to me and not off on their own. I'm trying to build a business that helps people. I just try to do the right thing as best I can.
Claudia Williams 1:38 ↗
Some people have called Cost Plus Drugs so obvious it's radical, which I think is a sad testament about the state of healthcare. Is it radical? What made it possible? And
Mark Cuban 1:48 ↗
What makes it what makes it radical is when we started, everybody presumed and expected that we would work within the system, that we would partner with the big three wholesalers that control 98% of the of the sale of drugs, that we would partner with the big three PBMs that control 85% of prescriptions. And we did the exact opposite because we knew they were the problem, right? And by working with them and having any level of dependency on them, that we couldn't be disruptive. And so that was part one. Part two to costplusdrugs.com is we show our costs. And so when you go to costplusdrugs.com and you put in the name of the medication, presuming it's one of the thousands we carry, when it comes up, you see exactly what we pay. You see our markup, which is always 15%. And then there's $5 for shipping and pharmacy fee, same for pharmacy fee. And so, it's that being that transparent was radically different and truly has changed the game.
Claudia Williams 2:54 ↗
One of the things that's confounding this market is often the big health plans that are purchasing care and drugs for most Americans who are employed are also the owners of PBMs, interestingly. And so, you don't see a lot of... Right. Shocking. So it's perhaps not surprising that those big national insurers aren't the ones leading the charge on trying to disrupt that market. How do you go about disrupting that other than through your model?
Mark Cuban 3:19 ↗
There are 161 million people covered by self-insured employers. You know, I've disrupted multiple industries, and healthcare has been the easiest to disrupt. And the reason for that is I can go to a CEO knowing that they don't really understand their benefits, right? It's not their core competency. They're trying to run a company, but it also is their second largest expense item after payroll, and it's becoming more and more evident that it's a problem for them. This is the first time ever where I can say, 'No, it's better and it's cheaper, and it's just a question of you going through the process.' Now, for some, that's more work than they want to deal with. For others, they're addicted to the rebates from the PBMs, and they don't care about the impact on their members. They just like getting that check. And then I explain to them that it's your sickest employees that pay for those rebates because they have to continually utilize medications that offer rebates. And most corporate sponsors have $1,500 to $2,500 deductibles, which isn't enormous relatively speaking, like to the ACA. But for a lot of people, if your take-home pay is $30,000, $40,000, that's a big number. And if you're using, just using this as an example, if you have a $2,000 deductible and you're, you know, you have Eliquis, which is a $600 WAC price, list price, you're paying $600 a month for three months, and whatever the rebate on that is, probably 50, 60% is going right into the pocket of the PBM/insurance company. So because of this deal you signed, on one hand, you're complaining that healthcare costs and pharmacy costs are going up faster than you ever expected, but on the other hand, you're signing the deals that are causing them to go up so quickly. You know, the first thing I always tell them to do, and I suggest this to everybody, just go to your PBM and say you'd like to add Cost Plus Drugs to your network, and that you'll only use it where we're cheaper. There's no exclusivity, there's no requirements. It's not like a PBM and their specialty pharmacies.
Cost Plus Drugs doesn't have exclusives with anybody. So, if we're cheaper, right, that just benefits your members. And they always go and they ask, and they always get told no. No one's ever been told yes. And the PBMs then give you 15 different reasons why they do this, this, this, why they're cheaper. Then I'm like, if they're cheaper, ask for the per claim price. Go ahead and just ask them for all your claims. And if you're like 500,000 members or more, you probably have all this. But everybody else, you can have thousands of members, 10,000 members, and you won't have all your claims, and you certainly won't have a net price per claim. You certainly won't know what the net rebates are. And I tell them to go ask, and they get told no, or they're told, 'Here's 300 claims.' And then I say, 'Go, here's a company that'll audit them, right?' And every single audit I've ever seen, there's never been one time where the company got overpaid. Then I ask the last question: What is it about the big PBMs that is unique or differentiated that isn't available elsewhere? If you had one thing, raise your hand. Nobody's ever raised their hand. That's how bad it is. And so it's just our job to educate the people who make the decisions, and not just in employers. Like I was talking to a state today, and they were complaining to me about the PBMs and the insurance companies, and I'm like, which one do you deal with? And they list one of the ones. I'm like, you're not allowed to complain if you're signing deals with these people because you're creating this problem because you're a huge state with all these members and you're making it more difficult for all your members. And then I went with them. I went through the whole, you know, deductible and how you're paying list price while you're on your deductible. If you're able as a state or as an employer to require net pricing as opposed to WAC pricing with rebates, then all of this changes.
The whole dynamic changes, and your employees will be paying a net price plus a little markup versus the retail price at twice as much, if not more. And so it's, you know, to answer your question, and sorry for the long-winded answer, it's more about the fact that employers, states, all the people who make these decisions don't understand how the economics work, so they sign bad deals.
Claudia Williams 7:51 ↗
I'm going to ask you to look back and look forward. Tell us about the first moment this occurred to you. This was not an obvious pathway for you. If you look at your history, what was the moment where you're like, gosh darn it, I have to, like, this is when I have to figure it out.
Mark Cuban 8:06 ↗
Gosh darn it is what I was, was not what I said to myself.
Claudia Williams 8:09 ↗
This is a clean podcast. I don't want to change my rating, right?
Mark Cuban 8:14 ↗
I got an email, a cold email from a doctor, Alex Oshmayansky, who's now my co-founder, and he wanted to start a compounding pharmacy that manufactures sterile injectables that were on short supply because there's always a short supply list, and some drugs that you never expect — sterile water, Pitocin, pediatric cancer drugs — often go into short supply. So I was like, that's a good idea, I'm open to that, but let me dig in some more and understand this industry more and answer my questions. And this was right around the time the Pharma Bro was going to... And so I was like, how could this dude raise the price of this generic drug, Daraprim, by 7,500% or whatever it was? And then I started digging. I was like, this is the most opaque industry that I've ever seen in my entire life. This is like easy pickings. If we just create a website and we're able to, you know, buy drugs from a manufacturer and just are completely transparent about everything. I'm like, why don't we show our cost? I'm like, nobody does that. I'm like, 'Exactly. Why don't we show our markup?' Well, we're leaving money on the table. That's okay because every patient that does this will benefit, and there will be patients who otherwise couldn't afford their medications who now can get it and may not have to ration and can be healthy. It's worth it, right? It'll take us longer to make money, but that's okay. And so, on January 19th of 2022, almost four years ago, we started Cost Plus Drugs with 111 drugs. And let me just take one step back. Right around that same time we were launching, I got our 111 drugs, took the ones that cost $30 or more, and then with a lot of arm twisting, got our, for the Dallas Mavericks, got our claims and the prices paid for all the generics that we were buying. And I only used the ones costing $30 or more. The Mavs over an 18-month period spent $169,000. The cost of Cost Plus would have been $19,000.
Claudia Williams 10:14 ↗
Wow.
Mark Cuban 10:15 ↗
I'm like, 'Okay, this is the right path. This is definitely the right way.' And I did a couple TV shows and promotions and talked about it. And immediately, we were getting people who were buying cancer drugs that were saving hundreds of dollars a month, if not more. I mean, I had one friend from college who lost his insurance and had a drug called Darzalex, and he's like, 'Mark, they're telling me I'm going to have to pay $10,000 every three months.' And I'm like, 'Let me check.' We, you know, we were just getting started, hadn't carried it yet. We got it, and at that point in time his price, I forget exactly, like $79 a month is what we got him for, and he was crying. And then we got the price down lower as we grew. And so it was just those types of inefficiencies that we were able to solve. And so once we launched and saw our initial volume and then just the feedback and responses we got, I knew we're on the right path.
Claudia Williams 11:07 ↗
I love that it came from a cold email because you responded very quickly to my email. You do not know me. So it pays to answer cold emails. All you people out there with the big boxes, you don't answer. Five years from now, where do you want to be?
Mark Cuban 11:22 ↗
We want to have the entire healthcare industry be 180 degrees different. We want there to be complete transparency. We want to carry all drugs. You know, there's certain brands that won't sell to us for a variety of reasons. We want to have an impact on medical care as well. We're working on direct contracting programs for my members, the members that I self-insure and pay for. And we think we may be able, maybe not get all the way there obviously, but have a significant impact. I don't have to, you know, it's not like I have to make a lot of money if I just turn this industry upside down so that, you know, people just match our prices because there's a lot of people who don't buy their drugs from costplusdrugs.com but have their PBMs or their insurers have to match our pricing. Like when I just gave the Senate testimony last week, one of the things that the guy from Cigna said, Dr. Mould said, was we used Cost Plus Drugs' price list in our negotiations with the PBMs, which got us lower pricing, and that happens all the time. And that's one of the reasons the PBMs and insurance companies hate us because the smartest thing we did was publish our price list and make it available to everybody. So now, you know, research organizations can look and see, you know, that for, I forget which kind of, this list of medications, Medicare would have saved $6 billion if they would have bought through Cost Plus for oncology drugs, $900 million, etc. Corporations are doing the same thing, and they're going back to their PBMs, and their PBMs are now having to give them more in rebates or pass-throughs or reduced fees. But you know, so it's paying off. Unfortunately, the PBMs are smarter than the CEOs and the people doing the negotiations because they just change fees. And I tell everybody now, if you have a PBM contract or insurance contract, stick it into Gemini, Perplexity, and ChatGPT and just say, 'What am I missing? What am I not noticing on this contract that's bad for me?' And it'll pop up.
Claudia Williams 13:29 ↗
Great stuff. So you kind of alluded to looking around healthcare and seeing other opportunities to disrupt. If you were to pick another sector or subsector within healthcare that has similar disruption opportunities, what would it be, and why, and how would you get going?
Mark Cuban 13:47 ↗
Well, we're starting something called Cost Plus Wellness, which is for my own companies, the members that I, because I self-insure and so I'm responsible for paying. It's left pocket, right pocket for me. And it was always just as it was insane that the Pharma Bro could jack up Daraprim, it's crazy to me that the biggest insurance companies, when you look at the price transparency files for hospitals, their prices are sometimes two or three times as much as any John Doe walking into a provider with a credit card to pay cash. And so I started telling our people, no, you know, before, unless it's an emergency and you have to go now, let us call, get the cash price, and we'll just pay with the company credit card. And that saved me a bunch of money. So I'm like, we need to formalize this. And so direct contracts...
Claudia Williams 14:32 ↗
Hold on a minute. So you're a big employer. All of these organizations would be happy to have your business. Your person shows up at the door, and if they say they're with the company, the charge is going to be 10 times higher than if they're an individual. I mean, we've all experienced this when we go pay for drugs and they accidentally give us the price if we're...
Mark Cuban 14:50 ↗
The cash price. Yeah. Yeah.
Claudia Williams 14:52 ↗
Then they're like, 'Oh, no, no, no. That's not it. It's this.' But I'm just like, it's such an illogical statement you just said. I mean, what you did is brilliant, but...
Mark Cuban 15:01 ↗
It makes no sense at all that the biggest insurance companies that do hundreds of billions of dollars in sales can't negotiate a better price than anybody who walks in the door with a credit card that does no negotiation whatsoever. And when I would talk to hospital CEOs and CFOs and ask them to tell me about what it's like to deal with the insurance companies and the problem issues, you start digging in and it's insane, right? Not just a cash pay. So the reason we're able to do direct contracting is because the hospitals get abused by the insurance companies in a lot of ways. Not always, because sometimes the hospital will have more power in a given market, but most of the time, and here's the way it works: the contracted price with the insurance company is $25,000. Somebody who's covered goes in to get a hip replacement. You would think they just pay $25,000, but they don't. They underpay you and basically say, 'If you don't like it, sue me.' And so now the provider, the hospital network, loses 3 to 5% just because of those underpayments. And they have all these administrators and lawyers who have to deal with it trying to collect it, right? The third piece is the prior authorizations. The prior authorizations aren't just about denying care. It's about delaying care because the longer they have your premium money, the more interest that they can earn that the provider hasn't been paid yet and doesn't earn. And by the way, the hospital and the provider have doctors that are wasting all this time trying to get the denial overturned so their patient can get the care that they've chosen or prescribed, right? So all these things add up from the hospital or provider's perspective as being very cost-heavy, and that's why we hear all these stories about administration fees and overhead costing 20 to 30% of the $5 trillion we spend every year. It's all those things. So we went to hospitals and we said we want your cash price, but in exchange for that cash price, and where you don't have a cash price because there's not one for everything, we want to pay some percentage of Medicare. It could be 80% if it's an MRI. It could be 120%. It could be 150%. We'll negotiate with all the different providers, and we're not going to be exclusive to any. But here's the key: by the time our patient has gotten to you, there's no pre-ops. We've already ascertained whether or not we're going to pay for it. So your doctors waste no time, right? And you get the money. We're going to pay you right away, and we're going to pay you exactly what we negotiated for. There's no underpayment, none of those games, no administrative burden to deal with it. And they like it. And so, so far we're up to 9,000 doctors, providers. And we called this program Cost Plus Wellness. And here's the money shot, though, right? What's key is we're going to take all those contracts we negotiate and we're going to publish them on costpluswellness.com. So that any company can look at it, any individual can look at it.
Claudia Williams 18:12 ↗
Yeah. Just as an anecdote, my friend Dave deBronkert is one of the most amazing patient innovators I know. Needed a knee surgery or something, and he tried to get prices. He called around, and they basically said, they actually said, 'We don't know our prices. Like, we can't give you a price.'
Mark Cuban 18:28 ↗
No, it's even worse than that. They don't know their costs. Like, I paid for a study — now this has been five, six years ago — or I was part of a study in this case, and I asked them to have kids just call up hospitals and ask for the cash price and compare it to the published cash price, and like 60% of the time, you know, whatever it was, it didn't match. We want it to be radically transparent. We don't sell it. We just make it available, and it's not launched yet, but hopefully by the end of the year, costpluswellness.com will have all these contracts.
Claudia Williams 19:02 ↗
Will you also expand, like manage that process for other employers that might want to work with you?
Mark Cuban 19:08 ↗
No, we're just, they'll be in consultants. We're not, this is not a business for us. This is us publishing this data for anybody to use as they will. But we're expecting two things will happen. One, when we publish all the cash prices, we'll get a lot of grief because other companies will have gotten better pricing, and we'll be able to go back to those providers and say they're getting better pricing over here, right? What would you like us to do? Because we're not exclusive to any of them, and we can shop. And so, you know, the other thing, what we are recommending to employers is that they hire a healthcare CEO who is kind of a care navigator that all they do is act as the pre-authorization and negotiator for anything that's expensive for your members. So, if you need a surgery, you know, let's go find a doctor that you like if you don't already have one. And if you do have one, let us negotiate with your doctor to see if I can get a cash price. And if you do this, there will be no cash out of pocket to you.

28 more exchanges in this transcript

Sign in free to read the rest of this interview. No card required.

Sign in to read the full transcript

Cite this transcript

APA, MLA, BibTeX
APA

Cuban, M. (2025, December 3). Mark Cuban on Breaking the System: From Big Pharma to Doing What’s Right [Interview transcript]. The Other 80. CEOInterviews.AI. https://ceointerviews.ai/interview/3391629/

MLA

Mark Cuban. "Mark Cuban on Breaking the System: From Big Pharma to Doing What’s Right." The Other 80, 3 Dec. 2025. Transcript, CEOInterviews.AI, https://ceointerviews.ai/interview/3391629/.

BibTeX
@misc{cuban2025_3391629,
  author       = {Mark Cuban},
  title        = {Mark Cuban on Breaking the System: From Big Pharma to Doing What’s Right},
  howpublished = {Interview transcript, The Other 80. CEOInterviews.AI},
  year         = {2025},
  month        = {dec},
  url          = {https://ceointerviews.ai/interview/3391629/},
  note         = {Speaker-attributed transcript with timestamps}
}